Wall Street Zen Upgrades H. B. Fuller (NYSE:FUL) to “Strong-Buy”

H. B. Fuller (NYSE:FUL) was upgraded by investment analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Saturday.

A number of other research firms have also commented on FUL. Citigroup lifted their price objective on H. B. Fuller from $67.00 to $70.00 and gave the stock a “buy” rating in a research note on Monday, March 30th. UBS Group set a $69.00 price objective on shares of H. B. Fuller in a research note on Friday. Royal Bank Of Canada set a $58.00 target price on H. B. Fuller in a report on Wednesday, May 27th. JPMorgan Chase & Co. raised shares of H. B. Fuller from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $58.00 to $67.00 in a report on Friday. Finally, Raymond James Financial set a $67.00 price objective on H. B. Fuller in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $66.33.

H. B. Fuller Stock Performance

Shares of H. B. Fuller stock opened at $63.20 on Friday. H. B. Fuller has a 12 month low of $48.71 and a 12 month high of $68.63. The stock has a market cap of $3.44 billion, a PE ratio of 20.86, a price-to-earnings-growth ratio of 0.81 and a beta of 0.96. The company has a quick ratio of 1.15, a current ratio of 1.80 and a debt-to-equity ratio of 1.00. The business has a fifty day simple moving average of $61.64 and a 200-day simple moving average of $61.30.

H. B. Fuller (NYSE:FUL) last posted its quarterly earnings results on Wednesday, June 24th. The specialty chemicals company reported $1.41 EPS for the quarter, beating the consensus estimate of $1.37 by $0.04. The business had revenue of $950.27 million for the quarter, compared to analysts’ expectations of $924.83 million. H. B. Fuller had a net margin of 5.29% and a return on equity of 12.18%. H. B. Fuller’s revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the company posted $1.18 EPS. H. B. Fuller has set its FY 2026 guidance at 4.600-4.900 EPS. On average, sell-side analysts anticipate that H. B. Fuller will post 4.78 EPS for the current fiscal year.

Insider Buying and Selling

In other H. B. Fuller news, CEO Celeste Beeks Mastin acquired 5,170 shares of H. B. Fuller stock in a transaction dated Tuesday, April 7th. The stock was bought at an average cost of $57.08 per share, for a total transaction of $295,103.60. Following the purchase, the chief executive officer directly owned 8,670 shares in the company, valued at approximately $494,883.60. This represents a 147.71% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 1.83% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Norges Bank bought a new position in H. B. Fuller during the 4th quarter worth $44,203,000. Royal Bank of Canada lifted its stake in H. B. Fuller by 2,694.7% in the first quarter. Royal Bank of Canada now owns 675,765 shares of the specialty chemicals company’s stock valued at $41,681,000 after buying an additional 651,585 shares during the period. UBS Group AG lifted its position in shares of H. B. Fuller by 200.8% during the 3rd quarter. UBS Group AG now owns 820,871 shares of the specialty chemicals company’s stock valued at $48,661,000 after acquiring an additional 548,017 shares during the period. Verition Fund Management LLC raised its holdings in shares of H. B. Fuller by 1,379.5% during the fourth quarter. Verition Fund Management LLC now owns 383,955 shares of the specialty chemicals company’s stock valued at $22,830,000 after purchasing an additional 358,003 shares during the period. Finally, Goldman Sachs Group Inc. raised its stake in H. B. Fuller by 52.3% during the 4th quarter. Goldman Sachs Group Inc. now owns 820,255 shares of the specialty chemicals company’s stock worth $48,772,000 after buying an additional 281,707 shares during the period. 95.93% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about H. B. Fuller

Here are the key news stories impacting H. B. Fuller this week:

• Positive Sentiment: J.P. Morgan upgraded H. B. Fuller (FUL) from neutral to overweight and lifted its price target to $67 from $58, citing optimism around EBITDA growth. Benzinga report on JPMorgan upgrade
• Positive Sentiment: The company reported strong Q2 results, with EPS of $1.41 and revenue of $950.3 million, both above expectations, which supports the stock’s recent strength. Zacks earnings beat article
• Neutral Sentiment: H. B. Fuller announced a recommended cash offer to acquire Advanced Medical Solutions Group for about $942 million including debt, reinforcing its push into medical adhesives but also adding integration and financing risk. BusinessWire acquisition announcement
• Neutral Sentiment: The company also outlined a FY2026 EBITDA target range of $650 million to $675 million as it advances the AMS deal, which gives investors a clearer outlook but does not remove acquisition uncertainty. Seeking Alpha EBITDA guidance article
• Negative Sentiment: Some investors and activists criticized the AMS purchase as too expensive or risky, and the stock sold off as shareholders weighed the deal’s size and execution risk. Ancora statement on acquisition opposition

H. B. Fuller Company Profile

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.